Physician profile
Robert Decaro
NPI 1285814632
$2,397.33
in general payments reported to CMS, 2019-2025
20 companies · $456 in 2025
The $456 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $297 · 2022: $410 · 2023: $470 · 2024: $764 · 2025: $456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,691.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,690.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $737.37 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $540.87 | 2022-2025 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $180.33 | 2023 | Intracept |
| Nalu Medical, INC. | $178.26 | 2024 | Nalu Neurostimulation System |
| Forte Bio-Pharma LLC | $126.08 | 2023-2024 | Prolate, Nalocet |
| Vertex Pharmaceuticals Incorporated | $99.65 | 2025 | |
| Scilex Pharmaceuticals INC. | $73.74 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.60 | 2021-2024 | Relistor |
| Biodelivery Sciences International, INC. | $54.47 | 2021 | |
| Valinor Pharma, LLC | $51.12 | 2024-2025 | Movantik |
| Pfizer INC. | $47.03 | 2024 | |
| Si-Bone, INC. | $46.59 | 2023-2024 | |
| Octapharma USA, INC. | $36.83 | 2024 | Fibryga |
| Hikma Pharmaceuticals USA | $32.00 | 2022 | |
| Avanos Medical | $31.74 | 2025 | Trays- All |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $26.36 | 2025 | |
| Tonix Medicines, INC. | $19.26 | 2025 | Tonmya |
| Nevro Corp. | $18.69 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $18.37 | 2024 | Ajovy |
| Horizon Therapeutics Plc | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Decaro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.